MedTrace Logo

Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer Patients

NCT05566613 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2022-10-04

No results posted yet for this study

Summary

Non-randomized clinical cohort study investigating if single nucleotide polymorphism (SNP) or inflammatory markers can predict radiosensitivity in breast cancer patients receiving radiotherapy.

Conditions

  • Radiation Tolerance
  • Breast Neoplasms

Interventions

RADIATION

Blood sample

Blood sample before and after radiotherapy and photography before radiotherapy

Sponsors & Collaborators

  • Stockholm University

    collaborator OTHER

  • Karolinska University Hospital

    lead OTHER

Principal Investigators

  • Mattias Hedman, MD PhD · Karolinska University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-09
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05566613 on ClinicalTrials.gov